Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma

被引:4
作者
Brady, Michael T. [1 ,2 ]
Laniewski, Nathan [3 ]
Strawderman, Myla [4 ]
Chu, Charles C. [1 ,2 ]
Kanagaiah, Preshetha [3 ]
Sangster, Mark Y. [3 ]
Topham, David J. [3 ]
Friedberg, Jonathan W. [1 ,2 ]
Zent, Clive S. [1 ,2 ]
机构
[1] Univ Rochester, Wilmot Canc Inst, Med Ctr, Rochester, NY USA
[2] Univ Rochester, Dept Med, Med Ctr, Rochester, NY USA
[3] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Med Ctr, Dept Microbiol & Immunol, Rochester, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY USA
关键词
D O I
10.1002/ajh.27038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E288 / E290
页数:3
相关论文
共 7 条
[1]   VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study [J].
Asada, Hideo .
VACCINE, 2019, 37 (44) :6776-6781
[2]   Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab [J].
Bacova, Barbora ;
Kohutova, Zuzana ;
Zubata, Ivana ;
Gaherova, Lubica ;
Kucera, Petr ;
Heizer, Tomas ;
Mikesova, Marcela ;
Karel, Tomas ;
Novak, Jan .
HAEMATOLOGICA, 2022, 107 (12) :2988-2989
[3]   Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older [J].
Cunningham, Anthony L. ;
Heineman, Thomas C. ;
Lal, Himal ;
Godeaux, Olivier ;
Chlibek, Roman ;
Hwang, Shinn-Jang ;
McElhaney, Janet E. ;
Vesikari, Timo ;
Andrews, Charles ;
Choi, Won Suk ;
Esen, Meral ;
Ikematsu, Hideyuki ;
Choma, Martina Kovac ;
Pauksens, Karlis ;
Ravault, Stephanie ;
Salaun, Bruno ;
Schwarz, Tino F. ;
Smetana, Jan ;
Vanden Abeele, Carline ;
Van den Steen, Peter ;
Vastiau, Ilse ;
Weckx, Lily Yin ;
Levin, Myron J. .
JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (11) :1750-1760
[4]   Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis [J].
Dagnew, Alemnew F. ;
Ilhan, Osman ;
Lee, Won-Sik ;
Woszczyk, Dariusz ;
Kwak, Jae-Yong ;
Bowcock, Stella ;
Sohn, Sang Kyun ;
Rodriguez Macias, Gabriela ;
Chiou, Tzeon-Jye ;
Quiel, Dimas ;
Aoun, Mickael ;
Navarro Matilla, Maria Belen ;
de la Serna, Javier ;
Milliken, Samuel ;
Murphy, John ;
McNeil, Shelly A. ;
Salaun, Bruno ;
Di Paolo, Emmanuel ;
Campora, Laura ;
Lopez-Fauqued, Marta ;
El Idrissi, Mohamed ;
Schuind, Anne ;
Heineman, Thomas C. ;
Van den Steen, Peter ;
Oostvogels, Lidia .
LANCET INFECTIOUS DISEASES, 2019, 19 (09) :988-1000
[5]   Perturbation of the normal immune system in patients with CLL [J].
Forconi, Francesco ;
Moss, Paul .
BLOOD, 2015, 126 (05) :573-581
[6]   BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL [J].
Pleyer, Christopher ;
Laing, Kerry J. ;
Ali, Mir A. ;
McClurkan, Christopher L. ;
Soto, Susan ;
Ahn, Inhye E. ;
Nierman, Pia ;
Maddux, Emeline ;
Lotter, Jennifer ;
Superata, Jeanine ;
Tian, Xin ;
Wiestner, Adrian ;
Cohen, Jeffrey, I ;
Koelle, David M. ;
Sun, Clare .
BLOOD ADVANCES, 2022, 6 (06) :1732-1740
[7]   Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma [J].
Zent, Clive S. ;
Brady, Michael T. ;
Delage, Carolyne ;
Strawderman, Myla ;
Laniewski, Nathan ;
Contant, Phuong N. ;
Kanagaiah, Preshetha ;
Sangster, Mark Y. ;
Barr, Paul M. ;
Chu, Charles C. ;
Topham, David J. ;
Friedberg, Jonathan W. .
LEUKEMIA, 2021, 35 (06) :1788-1791